CIK 0001527753 · Non-accelerated filer<br>Smaller reporting company
Personalis, Inc.
Sign in to watch- Ticker
- PSNL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275411038
- Phone
- 650-752-1300
- Business address
- 6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $728,924
- in 5 filings
Net −$728,924. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-03 | Hall Christopher M Chief Executive Officer | Sale | −29,112 | $15.87 | $462K | 199,415 |
| 2026-09-18 | Hall Christopher M Chief Executive Officer | Sale | −7,459 | $16.22 | $121K | 228,527 |
| 2026-07-09 | Hall Christopher M Chief Executive Officer | Option exercise 10b5-1 | +100,000 | $1.61 | $161K | 335,986 |
| 2026-07-09 | Hall Christopher M Chief Executive Officer | Sale 10b5-1 | −100,000 | $15.08 | $1.5M | 235,986 |
| 2026-07-09 | Hall Christopher M Chief Executive Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −66,667 | 133,333 | ||
| 2026-07-09 | Hall Christopher M Chief Executive Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −33,333 | 0 | ||
| 2026-06-26 | Hall Christopher M Chief Executive Officer | Option exercise 10b5-1 | +100,000 | $1.61 | $161K | 335,986 |
| 2026-06-26 | Hall Christopher M Chief Executive Officer | Sale 10b5-1 | −100,000 | $13.15 | $1.3M | 235,986 |
| 2026-06-26 | Hall Christopher M Chief Executive Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −100,000 | 200,000 | ||
| 2026-05-29 | Hall Christopher M Chief Executive Officer | Option exercise 10b5-1 | +80,091 | $1.61 | $129K | 316,077 |
| 2026-05-29 | Hall Christopher M Chief Executive Officer | Sale 10b5-1 | −80,091 | $11.02 | $883K | 235,986 |
| 2026-05-29 | Hall Christopher M Chief Executive Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −80,091 | 300,000 | ||
| 2026-05-28 | Hall Christopher M Chief Executive Officer | Option exercise 10b5-1 | +19,909 | $1.61 | $32K | 255,895 |
| 2026-05-28 | Hall Christopher M Chief Executive Officer | Sale 10b5-1 | −19,909 | $11.02 | $219K | 235,986 |
| 2026-05-28 | Hall Christopher M Chief Executive Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −19,909 | 380,091 | ||
| 2026-03-15 | Hall Christopher M Chief Executive Officer | Grant or award | +87,500 | 235,986 | ||
| 2026-03-15 | Hall Christopher M Chief Executive Officer | Grant or award · Stock Option (right to buy) | +525,000 | 525,000 | ||
| 2026-02-23 | Hall Christopher M PRESIDENT AND CEO | Grant or award · Stock Option (right to buy) | +33,333 | 33,333 | ||
| 2025-11-03 | Hall Christopher M PRESIDENT AND CEO | Sale | −29,612 | $8.99 | $266K | 148,486 |
| 2025-03-15 | Hall Christopher M PRESIDENT AND CEO | Grant or award · Stock Option (right to buy) | +680,000 | 680,000 |
Page 1 of 2 · 24 trades